Clinical Trials Archives - Page 2 of 2

A new cancer treatment (known as monoclonal antibodies) is helping COVID-19 patients with underlying conditions avoid hospitalization.

A promising new artificial intelligence (AI) tool could streamline the process of identifying mesothelioma tumors in patients.

Preliminary data from a study done by Targovax show a numerical advantage in Progression-Free Survival in patients treated with ONCOS-102.

Phase II of a clinical trial involving surgery, radiation, and chemotherapy is actively recruiting patients with pleural mesothelioma.

The European Thoracic Oncology Platform (ETOP) recently completed a disappointing phase 3 trial for mesothelioma treatment.

Phase II of a clinical trial is recruiting mesothelioma patients to test the effectiveness of two immunotherapy medications in combination.

Mesothelioma Hub is dedicated to helping you find information, support, and advice. Reach out any time!

New Cancer Treatment Helps High-risk Covid Patients Avoid Hospital